SCHEMBL9511004

SCHEMBL9511004

CCCCc1ncc(C=C(CCc2ccc3c(c2)OCO3)C(=O)O)n1Cc1ccccc1Cl

nearest known ligand 0.87

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ AGTR1 P30556 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7052812 0.93 — —
SCHEMBL7052807 0.93 — —
Hydrochloric Acid SCHEMBL8954290 0.84 AGTR1 (0.73) AGTR1
Hydrochloric Acid SCHEMBL8954288 0.84 AGTR1 (0.73) AGTR1
SCHEMBL8160507 0.83 AGTR1 (0.58) AGTR1
SCHEMBL8160504 0.83 AGTR1 (0.58) AGTR1
SCHEMBL9424433 0.82 AGTR1 (0.75) AGTR1
SCHEMBL9424090 0.81 — —
SCHEMBL9424094 0.81 — —
SCHEMBL9424338 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0561878-A1 USE OF ANGIOTENSIN II ANTAGONIST IN THE TREATMENT OF INFARCTION SMITHKLINE BEECHAM PLC (GB) 1993-09-29 — — EP disclosed
Send feedback